Stay updated on Nivolumab and Relatlimab in Melanoma Clinical Trial

Sign up to get notified when there's something new on the Nivolumab and Relatlimab in Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab and Relatlimab in Melanoma Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The page has been updated to reflect a new version of the HHS Vulnerability Disclosure, changing from v2.16.6 to v2.16.8.
    Difference
    0.1%
    Check dated 2025-07-26T00:24:11.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.5 to version 2.16.6.
    Difference
    0.1%
    Check dated 2025-07-18T21:30:50.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    The web page now includes a service alert regarding planned maintenance starting July 25th, during which most services will be unavailable for over 24 hours. Additionally, the section indicating 'No Results Posted' has been removed.
    Difference
    0.8%
    Check dated 2025-07-11T17:16:40.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    The page has been updated to version v2.16.5, and the previous version v2.16.4 has been removed from the content. Additionally, a significant note regarding the modernization of ClinicalTrials.gov data ingest has been deleted.
    Difference
    0.9%
    Check dated 2025-07-04T13:00:25.000Z thumbnail image
  5. Check
    34 days ago
    No Change Detected
  6. Check
    41 days ago
    Change Detected
    Summary
    The expected modernization date for the ClinicalTrials.gov data ingest has been updated from June 2025 to July 2025.
    Difference
    0.7%
    Check dated 2025-06-20T04:46:47.000Z thumbnail image
  7. Check
    48 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.2 to version 2.16.3.
    Difference
    0.1%
    Check dated 2025-06-13T00:49:41.000Z thumbnail image

Stay in the know with updates to Nivolumab and Relatlimab in Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab and Relatlimab in Melanoma Clinical Trial page.